The Francis Crick Institute
Browse
1-s2.0-S1873506122003038-main.pdf (4.37 MB)

Generation of FOUR iPSC lines (CRICKi004-A; CRICKi005-A; CRICKi006-A, CRICKi007-A) from spinal muscle atrophy patients with lower extremity dominant (SMALED) phenotype.

Download (4.37 MB)
journal contribution
posted on 2022-11-07, 14:21 authored by Liani G Devito, Fay Cooper, Ilenia D'Angelo, Jim Smith, Lyn Healy
Spinal muscular atrophy with lower extremity dominant (SMALED) is a hereditary neuromuscular disorder characterized by degeneration of spinal cord motor neurons resulting in lower limbs muscle weakness and paralysis. Mutations in DYNC1H1, which encodes BICD2, a multifunctional adaptor for microtubule motor proteins, cause the disorder. Here, we generated four induced pluripotent stem cell (iPSC) lines from patients with SMALED. Dermal fibroblasts were obtained from the MRC neuromuscular disease biobank and reprogrammed using non-integrating mRNA-based protocol. Characterization of the four iPSC lines included karyotyping and Sanger sequencing, while the expression of associated markers confirmed pluripotency and differentiation potential.

Funding

Crick (Grant ID: 10157, Grant title: Smith FC001157) Crick (Grant ID: CC1070, Grant title: STP HESCU)

History